1382EGP
- Active ingredient
- exemestane
- Strength
- 25mg
- Form
- tablet
- Manufacturer
- pfizer
- Route
- oral.solid
Uses
Used for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women and for advanced breast cancer after tamoxifen therapy.
Do not use if
Hypersensitivity to exemestane or any component of the formulation.
Side effects
Hot flushes, fatigue, joint pain, headache, insomnia, and decreased bone mineral density may occur.
Warnings
Monitor bone health and vitamin D status. May cause fetal harm if used during pregnancy.
How it works
Steroidal aromatase inhibitor that reduces estrogen production by blocking conversion of androgens to estrogens.
Storage
Store at 25°C; excursions permitted between 15°C and 30°C.
